Advertisement

Topics

Latest "Gleneagles Clinicial Research Centre Pte. Ltd" News Stories

18:55 EST 10th December 2018 | BioPortfolio

Here are the most relevant search results for "Gleneagles Clinicial Research Centre Pte. Ltd" found in our extensive news archives from over 250 global news sources.

More Information about Gleneagles Clinicial Research Centre Pte. Ltd on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Gleneagles Clinicial Research Centre Pte. Ltd for you to read. Along with our medical data and news we also list Gleneagles Clinicial Research Centre Pte. Ltd Clinical Trials, which are updated daily. BioPortfolio also has a large database of Gleneagles Clinicial Research Centre Pte. Ltd Companies for you to search.

Showing "Gleneagles Clinicial Research Centre" News Articles 1–25 of 29,000+

Monday 10th December 2018

Proton beam therapy in Europe: more centres need more research


As China's First and Only Host Institution for the Amgen Scholars Program, Tsinghua University is Accepting Global Applications

BEIJING, Dec. 10, 2018 /PRNewswire/ -- In November 2018, the Amgen Foundation expanded the Amgen Scholars Program (ASP) to 24 premier educational and research institutions worldwide. Tsinghua University was selected as the first and only Chinese host institution for the ASP and is now accepting global applications. The ASP is an undergraduate summer research program, initiated by the Amgen Found...

Thin Film Electronics (158355634THIN) - Thinfilm joins NFC Forum board of directors

Edison Investment Research - Technology - Thin Film Electronics: Thinfilm has announced that it has been voted onto the NFC Forum board of directors. This is the governing body of the organisation and as such is responsible for its budget, specification of standards and overall direction of NFC deployment. We leave our estimates unchanged.ISIN: NO0010299068


S&U (SUS) - Trading broadly in line

Edison Investment Research - Financials - S&U: S&U’s latest trading update indicates it is on track to deliver results close to expectations for the current year. Motor finance receivables growth slowed in the second half, which prompted a reduction in our estimates, primarily for FY20. We still look for a return on equity (ROE) of above 17% and believe the discipline shown in holding to...

Finsbury Growth & Income Trust (FGT) - Strong record of capital and dividend growth

Edison Investment Research - Investment Companies - Finsbury Growth & Income Trust: Finsbury Growth & Income Trust (FGT) has a distinguished track record of outperformance – its NAV total returns are above those of the FTSE All-Share index benchmark over one, three, five and 10 years. It also ranks first over these periods when comparing its performance with that of its 10 larger-cap pee...

Rebecca Leary of @Novartis works in the transformational field of biopharmaceutical research known as precision medicine. Learn how she is working to bring the promise of immunotherapy to patients. http://bit.ly/2SGY67i  #GoBoldlypic.twitter.com/q8v70xE

Rebecca Leary of @Novartis works in the transformational field of biopharmaceutical research known as precision medicine. Learn how she is working to bring the promise of immunotherapy to patients. http://bit.ly/2SGY67i  #GoBoldly pic.twitter.com/q8v70xEa01

Cake Box Holdings (United Kingdom) - Plain vanilla

Edison Investment Research - Consumer Support Services - Cake Box Holdings: What is rare about Cake Box’s investment case is that it is a unique concept which is also low-tech. The simplicity of the retail offer and of the franchise formula, management’s track record, the ungeared balance sheet, as well as continuing current like-for-like growth despite depressed consumer sentiment and...

Abramson Cancer Center Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 08112018] Prices from USD $250

SummaryAbramson Cancer Center Abramson formerly Penn Medicine's Cancer Center, a subsidiary of University of Pennsylvania is a healthcare service center that provides clinical trials for the prevention, diagnosis and treatment of cancer. The center provides supportive care services, which include integrative medicine and wellness, nutritional counseling, pastoral care, patient education and psycho...

Alliqua BioMedical Inc ALQA Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12102018] Prices from USD $250

SummaryAlliqua BioMedical Inc Alliqua BioMedical, formerly HepaLife Technologies Inc, is a regenerative technology company that builds a suite of regenerative solutions for wound and tissue repair. The company's products comprise ultrasound healing therapy, human biologics, antimicrobial protection and hydration. Its contract manufacturing business unit provides custom hydrogels to the OEM market....

The Trump administration wants to award $20 million in research grants for scientists to find alternatives to fetal tissue. https://buff.ly/2UyuSsQ 

The Trump administration wants to award $20 million in research grants for scientists to find alternatives to fetal tissue. https://buff.ly/2UyuSsQ 

Designing for Science: Igniting the Spark

ArticleAs one of North America’s premier, interdisciplinary, patient-focused research centers, HMRI has a long history of conducting leading-edge research.

NIH to spend up to $20 million on search for alternatives to fetal tissue for research

The Trump administration wants to award $20 million in research grants for scientists to find alternatives to fetal tissue.

Can Blockchain Technology and Artificial Intelligence Cure What Ails Biomedical Research and Healthcare

Can Blockchain Technology and Artificial Intelligence Cure What Ails Biomedical Research and Healthcare Curator: Stephen J. Williams, Ph.D. In the efforts to reduce healthcare costs, provide increased accessibility of service for patients, and drive biomedical innovations, many healthcare and biotechnology professionals have looked to advances in digital technology to determine the utility of IT t...

Is your college or university working on the most innovative advances in #science and #medicine? Then you should be entering into #statmaddnes! Our bracketed competition to find the top research institutions in the country. Enter here: https://buff.ly/2U

Is your college or university working on the most innovative advances in #science and #medicine? Then you should be entering into #statmaddnes! Our bracketed competition to find the top research institutions in the country. Enter here: https://buff.ly/2UxnNcb  pic.twitter.com/vCxKEp5cHX

A New Era of Emissions Testing Labs

ArticleThe new southern California headquarters of the California Air Resource Board will be the largest, most advanced regulatory vehicle emissions testing and research facility in the world—as well as the first zero net energy facility of its type.

Safe Orthopaedics SA SAFOR Medical Equipment Deals and Alliances Profile [Report Updated: 23102018] Prices from USD $250

SummarySafe Orthopaedics SA Safe Orthopaedics is medical device company that manufactures and markets devices for spinal surgery. The company's products comprise implants and surgical instruments. It offers modular cervical cages, percutaneous autocorrection screws, modular anchorage screws, percutaneous autocorrection screws and leaner positioning cages. Safe Orthopaedics also provides pedicle sc...

Auris Medical Holding AG EARS Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummaryAuris Medical Holding AG Auris Medical is a clinicalstage biopharmaceutical company with focus on neurotology and mental health supportive care. The company's pipeline product candidates are in various clinical phases intended for the treatment of acute inner ear tinnitus, postacute inner ear tinnitus, tinnitus, Meniere's disease Vertigo, sudden loss of hearing, antipsychoticinduced weight ...

.@AstraZeneca, @CR_UK launch Functional Genomics Centre; will use #CRISPR, #BigData and clinical insights to discover new targets and disease pathways in oncology https://www.astrazeneca.com/media-centre/press-releases/2018/astrazeneca-and-cancer-researc

. @AstraZeneca, @CR_UK launch Functional Genomics Centre; will use #CRISPR, #BigData and clinical insights to discover new targets and disease pathways in oncology https://www.astrazeneca.com/media-centre/press-releases/2018/ast

Immune Therapeutics Inc IMUN Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 08112018] Prices from USD $250

SummaryImmune Therapeutics Inc IMUN, formerly pH Environmental Inc, is a specialty pharmaceutical company that discovers, develops and commercializes patented therapies and technology such as Lodonal, LDN, CART and MENK. The company's patented therapies are focused on the activation and rebalancing and stimulating the body's immune system. Its patented therapies are used in the treatment of cancer...

Research Now SSI Opens New Operations Facility in Noida

DALLAS, Dec. 10, 2018 /PRNewswire/ -- Research Now SSI, a global leader in first-party data and data services, announces that it has opened a new Read more...

LeanMD Shares Weight Loss Tips to Help Keep New Year's Resolutions

SAN RAMON, Calif., Dec. 10, 2018 /PRNewswire/ -- According to a research, losing weight is consistently in the top three of most popular New Year Read more...

Personal Health: How to Foster Empathy in Children

Research shows that we are each born with a given number of neurons that participate in an empathetic response. But early life experience shapes how we act on it.

South Africa’s Science Academy Urges Update to Nation’s Genetics Law

(Nature) – South Africa needs to overhaul the laws and ethical guidelines that govern its genetics research, testing and databases, says its national science academy — especially given the country’s troubled history of race-based discrimination. The country has become a … Read More

Hemostemix Inc HEM Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 08112018] Prices from USD $250

SummaryHemostemix Inc Hemostemix, formerly Theravitae Inc, is a biotechnology company that develops, manufactures and commercializes proprietary autologous cell therapy for the treatment of ischemic diseases. The company's clinicalstage candidate includes ACP01, an autologous cell therapy for the treatment of critical limb ischemia. Its ACP01 is in Phase II clinical trial in Canada, and the US. Th...

Report: 30 Percent of Healthcare Databases Exposed Online

Heather Landi, Associate EditorHackers are using the Dark Web to buy and sell personally identifiable information (PII) stolen from healthcare organizations, and exposed databases are a vulnerable attack surface for healthcare organizations, according to a new cybersecurity research report.


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks